United States Artemisinin Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Artemisinin Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Artemisinin Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Artemisinin Overall Market Size
2.1 United States Artemisinin Market Size: 2021 VS 2027
2.2 United States Artemisinin Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Artemisinin Sales: 2016-2027
3 Company Landscape
3.1 Top Artemisinin Players in United States Market
3.2 Top United States Artemisinin Companies Ranked by Revenue
3.3 United States Artemisinin Revenue by Companies
3.4 United States Artemisinin Sales by Companies
3.5 United States Artemisinin Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Artemisinin Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Artemisinin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Artemisinin Players in United States Market
3.8.1 List of Tier 1 Artemisinin Companies in United States
3.8.2 List of Tier 2 and Tier 3 Artemisinin Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Artemisinin Market Size Markets, 2021 & 2027
4.1.2 Extraction From Artemisia Annua
4.1.3 Semisynthetic Artemisinin
4.2 By Type - United States Artemisinin Revenue & Forecasts
4.2.1 By Type - United States Artemisinin Revenue, 2016-2021
4.2.2 By Type - United States Artemisinin Revenue, 2022-2027
4.2.3 By Type - United States Artemisinin Revenue Market Share, 2016-2027
4.3 By Type - United States Artemisinin Sales & Forecasts
4.3.1 By Type - United States Artemisinin Sales, 2016-2021
4.3.2 By Type - United States Artemisinin Sales, 2022-2027
4.3.3 By Type - United States Artemisinin Sales Market Share, 2016-2027
4.4 By Type - United States Artemisinin Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Artemisinin Market Size, 2021 & 2027
5.1.2 Antimalarial Injections
5.1.3 Antimalarial Tablets
5.2 By Application - United States Artemisinin Revenue & Forecasts
5.2.1 By Application - United States Artemisinin Revenue, 2016-2021
5.2.2 By Application - United States Artemisinin Revenue, 2022-2027
5.2.3 By Application - United States Artemisinin Revenue Market Share, 2016-2027
5.3 By Application - United States Artemisinin Sales & Forecasts
5.3.1 By Application - United States Artemisinin Sales, 2016-2021
5.3.2 By Application - United States Artemisinin Sales, 2022-2027
5.3.3 By Application - United States Artemisinin Sales Market Share, 2016-2027
5.4 By Application - United States Artemisinin Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Overview
6.1.3 Sanofi Artemisinin Sales and Revenue in United States Market (2016-2021)
6.1.4 Sanofi Artemisinin Product Description
6.1.5 Sanofi Recent Developments
6.2 KPC Pharmaceuticals
6.2.1 KPC Pharmaceuticals Corporation Information
6.2.2 KPC Pharmaceuticals Overview
6.2.3 KPC Pharmaceuticals Artemisinin Sales and Revenue in United States Market (2016-2021)
6.2.4 KPC Pharmaceuticals Artemisinin Product Description
6.2.5 KPC Pharmaceuticals Recent Developments
6.3 Kerui nanhai
6.3.1 Kerui nanhai Corporation Information
6.3.2 Kerui nanhai Overview
6.3.3 Kerui nanhai Artemisinin Sales and Revenue in United States Market (2016-2021)
6.3.4 Kerui nanhai Artemisinin Product Description
6.3.5 Kerui nanhai Recent Developments
6.4 Guangxi xiancaotang
6.4.1 Guangxi xiancaotang Corporation Information
6.4.2 Guangxi xiancaotang Overview
6.4.3 Guangxi xiancaotang Artemisinin Sales and Revenue in United States Market (2016-2021)
6.4.4 Guangxi xiancaotang Artemisinin Product Description
6.4.5 Guangxi xiancaotang Recent Developments
6.5 Guilin Pharmaceutical
6.5.1 Guilin Pharmaceutical Corporation Information
6.5.2 Guilin Pharmaceutical Overview
6.5.3 Guilin Pharmaceutical Artemisinin Sales and Revenue in United States Market (2016-2021)
6.5.4 Guilin Pharmaceutical Artemisinin Product Description
6.5.5 Guilin Pharmaceutical Recent Developments
6.6 Natural Bio-engineering
6.6.1 Natural Bio-engineering Corporation Information
6.6.2 Natural Bio-engineering Overview
6.6.3 Natural Bio-engineering Artemisinin Sales and Revenue in United States Market (2016-2021)
6.6.4 Natural Bio-engineering Artemisinin Product Description
6.6.5 Natural Bio-engineering Recent Developments
6.7 BIONEXX
6.7.1 BIONEXX Corporation Information
6.7.2 BIONEXX Overview
6.7.3 BIONEXX Artemisinin Sales and Revenue in United States Market (2016-2021)
6.7.4 BIONEXX Artemisinin Product Description
6.7.5 BIONEXX Recent Developments
6.8 CAT KHANH
6.8.1 CAT KHANH Corporation Information
6.8.2 CAT KHANH Overview
6.8.3 CAT KHANH Artemisinin Sales and Revenue in United States Market (2016-2021)
6.8.4 CAT KHANH Artemisinin Product Description
6.8.5 CAT KHANH Recent Developments
6.9 BEEPZ
6.9.1 BEEPZ Corporation Information
6.9.2 BEEPZ Overview
6.9.3 BEEPZ Artemisinin Sales and Revenue in United States Market (2016-2021)
6.9.4 BEEPZ Artemisinin Product Description
6.9.5 BEEPZ Recent Developments
6.10 Novanat Bioresource
6.10.1 Novanat Bioresource Corporation Information
6.10.2 Novanat Bioresource Overview
6.10.3 Novanat Bioresource Artemisinin Sales and Revenue in United States Market (2016-2021)
6.10.4 Novanat Bioresource Artemisinin Product Description
6.10.5 Novanat Bioresource Recent Developments
7 United States Artemisinin Production Capacity, Analysis
7.1 United States Artemisinin Production Capacity, 2016-2027
7.2 Artemisinin Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Artemisinin Supply Chain Analysis
9.1 Artemisinin Industry Value Chain
9.2 Artemisinin Upstream Market
9.3 Artemisinin Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Artemisinin Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Artemisinin in United States Market
Table 2. Top Artemisinin Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Artemisinin Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Artemisinin Revenue Share by Companies, 2016-2021
Table 5. United States Artemisinin Sales by Companies, (MT), 2016-2021
Table 6. United States Artemisinin Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Artemisinin Price (2016-2021) & (USD/MT)
Table 8. Manufacturers Artemisinin Product Type
Table 9. List of Tier 1 Artemisinin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Artemisinin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Extraction From Artemisia Annua
Table 12. Major Manufacturers of Semisynthetic Artemisinin
Table 13. By Type - United States Artemisinin Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Artemisinin Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Artemisinin Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Artemisinin Sales (MT), 2016-2021
Table 17. By Type - United States Artemisinin Sales (MT), 2022-2027
Table 18. By Application - United States Artemisinin Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Artemisinin Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Artemisinin Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Artemisinin Sales (MT), 2016-2021
Table 22. By Application - United States Artemisinin Sales (MT), 2022-2027
Table 23. Sanofi Corporation Information
Table 24. Sanofi Description and Major Businesses
Table 25. Sanofi Artemisinin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 26. Sanofi Artemisinin Product
Table 27. Sanofi Recent Developments
Table 28. KPC Pharmaceuticals Corporation Information
Table 29. KPC Pharmaceuticals Description and Major Businesses
Table 30. KPC Pharmaceuticals Artemisinin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 31. KPC Pharmaceuticals Artemisinin Product
Table 32. KPC Pharmaceuticals Recent Developments
Table 33. Kerui nanhai Corporation Information
Table 34. Kerui nanhai Description and Major Businesses
Table 35. Kerui nanhai Artemisinin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 36. Kerui nanhai Artemisinin Product
Table 37. Kerui nanhai Recent Developments
Table 38. Guangxi xiancaotang Corporation Information
Table 39. Guangxi xiancaotang Description and Major Businesses
Table 40. Guangxi xiancaotang Artemisinin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 41. Guangxi xiancaotang Artemisinin Product
Table 42. Guangxi xiancaotang Recent Developments
Table 43. Guilin Pharmaceutical Corporation Information
Table 44. Guilin Pharmaceutical Description and Major Businesses
Table 45. Guilin Pharmaceutical Artemisinin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 46. Guilin Pharmaceutical Artemisinin Product
Table 47. Guilin Pharmaceutical Recent Developments
Table 48. Natural Bio-engineering Corporation Information
Table 49. Natural Bio-engineering Description and Major Businesses
Table 50. Natural Bio-engineering Artemisinin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 51. Natural Bio-engineering Artemisinin Product
Table 52. Natural Bio-engineering Recent Developments
Table 53. BIONEXX Corporation Information
Table 54. BIONEXX Description and Major Businesses
Table 55. BIONEXX Artemisinin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 56. BIONEXX Artemisinin Product
Table 57. BIONEXX Recent Developments
Table 58. CAT KHANH Corporation Information
Table 59. CAT KHANH Description and Major Businesses
Table 60. CAT KHANH Artemisinin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 61. CAT KHANH Artemisinin Product
Table 62. CAT KHANH Recent Developments
Table 63. BEEPZ Corporation Information
Table 64. BEEPZ Description and Major Businesses
Table 65. BEEPZ Artemisinin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 66. BEEPZ Artemisinin Product
Table 67. BEEPZ Recent Developments
Table 68. Novanat Bioresource Corporation Information
Table 69. Novanat Bioresource Description and Major Businesses
Table 70. Novanat Bioresource Artemisinin Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 71. Novanat Bioresource Artemisinin Product
Table 72. Novanat Bioresource Recent Developments
Table 73. Artemisinin Production Capacity (MT) of Key Manufacturers in United States Market, 2019-2021 (MT)
Table 74. United States Artemisinin Capacity Market Share of Key Manufacturers, 2019-2021
Table 75. Artemisinin Market Opportunities & Trends in United States Market
Table 76. Artemisinin Market Drivers in United States Market
Table 77. Artemisinin Market Restraints in United States Market
Table 78. Artemisinin Raw Materials
Table 79. Artemisinin Raw Materials Suppliers in United States Market
Table 80. Typical Artemisinin Downstream
Table 81. Artemisinin Downstream Clients in United States Market
Table 82. Artemisinin Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Artemisinin Product Picture
Figure 2. Artemisinin Segment by Type
Figure 3. Artemisinin Segment by Application
Figure 4. United States Artemisinin Market Overview: 2020
Figure 5. United States Artemisinin Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Artemisinin Revenue, 2016-2027 (US$, Mn)
Figure 7. Artemisinin Sales in United States Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Artemisinin Revenue in 2020
Figure 9. Extraction From Artemisia Annua Product Picture
Figure 10. Semisynthetic Artemisinin Product Picture
Figure 11. By Type - United States Artemisinin Sales Market Share, 2016-2027
Figure 12. By Type - United States Artemisinin Revenue Market Share, 2016-2027
Figure 13. By Type - United States Artemisinin Price (USD/MT), 2016-2027
Figure 14. Antimalarial Injections
Figure 15. Antimalarial Tablets
Figure 16. By Application - United States Artemisinin Sales Market Share, 2016-2027
Figure 17. By Application - United States Artemisinin Revenue Market Share, 2016-2027
Figure 18. By Application - United States Artemisinin Price (USD/MT), 2016-2027
Figure 19. Sanofi Artemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. KPC Pharmaceuticals Artemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Kerui nanhai Artemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Guangxi xiancaotang Artemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Guilin Pharmaceutical Artemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Natural Bio-engineering Artemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. BIONEXX Artemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. CAT KHANH Artemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. BEEPZ Artemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Novanat Bioresource Artemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. United States Artemisinin Production Capacity (MT), 2016-2027
Figure 30. Artemisinin Industry Value Chain
Figure 31. Marketing Channels